Humana (HUM)
(Delayed Data from NYSE)
$344.50 USD
+4.92 (1.45%)
Updated May 14, 2024 04:00 PM ET
After-Market: $344.23 -0.27 (-0.08%) 7:58 PM ET
3-Hold of 5 3
A Value B Growth C Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$344.50 USD
+4.92 (1.45%)
Updated May 14, 2024 04:00 PM ET
After-Market: $344.23 -0.27 (-0.08%) 7:58 PM ET
3-Hold of 5 3
A Value B Growth C Momentum A VGM
Zacks News
Pre-Markets in Red Before Key Economic Data
by Zacks Equity Research
Pre-Markets in Red Before Key Economic Data.
Pre-Market Futures Lower Ahead of JOLTS, U.S. Auto Sales
by Mark Vickery
Markets look to start a new trading day in the red after closing lower Monday. Bond yields, gold and oil are all up.
Health Insurance Stocks Drop: Insights Into the Late Monday Fall
by Kaibalya Pravo Dey
Higher costs and lower hikes in rates can lead to lower profit growth, which concerns investors.
Humana (HUM) Increases Despite Market Slip: Here's What You Need to Know
by Zacks Equity Research
Humana (HUM) concluded the recent trading session at $351.45, signifying a +1.36% move from its prior day's close.
Is It Worth Investing in Humana (HUM) Based on Wall Street's Bullish Views?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Humana (HUM) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
Humana (HUM) Sees a More Significant Dip Than Broader Market: Some Facts to Know
by Zacks Equity Research
Humana (HUM) closed the most recent trading day at $347.09, moving -0.42% from the previous trading session.
Humana (HUM), DUOS Unveil Program to Improve Veterans' Health
by Zacks Equity Research
Humana (HUM) collaborates with DUOS to develop a program that aims to provide personalized care and assure the well-being of Louisiana's Veteran community, who have a HUM MA plan and suffer from chronic conditions.
Humana (HUM) Stock Slides as Market Rises: Facts to Know Before You Trade
by Zacks Equity Research
Humana (HUM) concluded the recent trading session at $347.19, signifying a -0.28% move from its prior day's close.
CI or HUM: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
CI vs. HUM: Which Stock Is the Better Value Option?
Are These 3 Beaten-Down S&P 500 Members Worth a Look?
by Derek Lewis
The market has enjoyed a fantastic run in 2024, building nicely on last year???s gains. But not all have joined the party, specifically these three. Deep in the red year-to-date, are they worth a look?
Humana (HUM) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Humana (HUM) closed the most recent trading day at $345.15, moving -0.53% from the previous trading session.
Humana (HUM) Increases Yet Falls Behind Market: What Investors Need to Know
by Zacks Equity Research
In the latest trading session, Humana (HUM) closed at $339.08, marking a +0.34% move from the previous day.
Humana (HUM) Inks Value-Based Deal to Offer Better Kidney Care
by Zacks Equity Research
Humana (HUM) expands ties with Strive to offer high-quality kidney care to its Medicare Advantage members and thereby, aims to increase the customer base of the relevant business line.
Cardinal Health and Humana have been highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
Cardinal Health and Humana have been highlighted as Zacks Bull and Bear of the Day.
Bear of the Day: Humana (HUM)
by Derek Lewis
Increased costs have been a thorn in the side of Humana, with shares facing a nasty reaction post-earnings following its latest quarterly release.
CI vs. HUM: Which Stock Is the Better Value Option?
by Zacks Equity Research
CI vs. HUM: Which Stock Is the Better Value Option?
Humana (HUM) Stock Slides as Market Rises: Facts to Know Before You Trade
by Zacks Equity Research
In the closing of the recent trading day, Humana (HUM) stood at $350.32, denoting a -0.24% change from the preceding trading day.
Humana (HUM) Collaborates With Veda to Enhance Efficiency
by Zacks Equity Research
Humana (HUM) partners with Veda to enhance the quality of provider directories.
Is It Worth Investing in Humana (HUM) Based on Wall Street's Bullish Views?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Humana (HUM) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
CNC or HUM: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
CNC vs. HUM: Which Stock Is the Better Value Option?
CNC vs. HUM: Which Stock Is the Better Value Option?
by Zacks Equity Research
CNC vs. HUM: Which Stock Is the Better Value Option?
Humana (HUM) Q4 Earnings Miss on Higher Costs, '25 Target Pulled
by Zacks Equity Research
Humana (HUM) expects 2024 revenues to increase to around $113 billion.
Compared to Estimates, Humana (HUM) Q4 Earnings: A Look at Key Metrics
by Zacks Equity Research
While the top- and bottom-line numbers for Humana (HUM) give a sense of how the business performed in the quarter ended December 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Humana (HUM) Reports Q4 Loss, Tops Revenue Estimates
by Zacks Equity Research
Humana (HUM) delivered earnings and revenue surprises of -57.14% and 1.35%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Ahead of Humana (HUM) Q4 Earnings: Get Ready With Wall Street Estimates for Key Metrics
by Zacks Equity Research
Evaluate the expected performance of Humana (HUM) for the quarter ended December 2023, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.